Tianjin Key Laboratory of Cardiovascular Remodeling and Target Organ Injury, Institute of Cardiovascular Disease and Heart Center, Pingjin Hospital, Logistics University of the Chinese People's Armed Police Forces, Tianjin, China; and.
Am J Physiol Heart Circ Physiol. 2014 Feb 15;306(4):H598-609. doi: 10.1152/ajpheart.00585.2013. Epub 2013 Dec 13.
Recent studies have shown that the tonicity-responsive enhancer binding protein (TonEBP)/vascular endothelial growth factor-C (VEGF-C) signaling pathway-induced lymphangiogenesis provides a buffering mechanism for high salt (HS) intake-induced elevation of blood pressure (BP). Moreover, blocking of TonEBP/VEGF-C signaling by mononuclear phagocyte depletion can induce salt-sensitive hypertension in rats. We hypothesized that HS intake could have an impact on cardiac lymphangiogenesis, and regulation of VEGF-C bioactivity, which is largely through the main receptor for VEGFR-3, may modulate HS intake-induced left ventricular remodeling. We demonstrated upregulation of TonEBP, increased macrophage infiltration, and enhanced lymphangiogenesis in the left ventricles of spontaneously hypertensive rats (SHR) that were fed a HS diet (8.0% NaCl). Then, retrovirus vectors capable of overexpression (ΔNΔC/VEGF-C/Cys152Ser, used for overexpressing VEGF-C) and blocking (VEGFR-3-Rg, used for trapping of bioactive VEGF-C) of VEGF-C and control vector (pLPCX) were intravenously administered to SHR from week 9 of a 12-wk HS loading period. At the end of the HS challenge, overexpression of VEGF-C led to enhanced cardiac lymphangiogenesis, decreased myocardial fibrosis, and macrophage infiltration, preserved left ventricular functions, as well as decreased blood pressure level compared with the HS group and the control vector-treated HS group. In contrast, systemic blocking of VEGF-C was associated with elevation of blood pressure level and an exacerbation of hypertensive left ventricular remodeling, as indicated by increased fibrosis and macrophage infiltration, and diminished lymphangiogenesis. Hence, our findings highlight that VEGF-C/VEGFR-3 is a promising therapeutic target to attenuate hypertensive left ventricular remodeling induced by HS intake, presumably via blood pressure-dependent and -independent mechanisms.
最近的研究表明,张力响应增强子结合蛋白(TonEBP)/血管内皮生长因子-C(VEGF-C)信号通路诱导的淋巴管生成为高盐(HS)摄入引起的血压(BP)升高提供了缓冲机制。此外,单核吞噬细胞耗竭阻断 TonEBP/VEGF-C 信号可诱导大鼠盐敏感高血压。我们假设 HS 摄入会对心脏淋巴管生成产生影响,而 VEGF-C 生物活性的调节主要通过 VEGFR-3 的主要受体进行,可能调节 HS 摄入引起的左心室重构。我们证明了高盐饮食(8.0%NaCl)喂养的自发性高血压大鼠(SHR)左心室 TonEBP 上调、巨噬细胞浸润增加和淋巴管生成增强。然后,在 12 周 HS 负荷期的第 9 周开始,将能够过表达(ΔNΔC/VEGF-C/Cys152Ser,用于过表达 VEGF-C)和阻断(VEGFR-3-Rg,用于捕获生物活性 VEGF-C)VEGF-C 的逆转录病毒载体和对照载体(pLPCX)静脉内给予 SHR。在 HS 挑战结束时,与 HS 组和对照载体处理的 HS 组相比,过表达 VEGF-C 导致心脏淋巴管生成增加、心肌纤维化和巨噬细胞浸润减少、左心室功能得到保留以及血压水平降低。相比之下,系统阻断 VEGF-C 与血压水平升高和高血压左心室重构加重相关,表现为纤维化和巨噬细胞浸润增加以及淋巴管生成减少。因此,我们的研究结果表明,VEGF-C/VEGFR-3 是一种有前途的治疗靶点,可减轻 HS 摄入引起的高血压左心室重构,可能通过血压依赖性和非依赖性机制。